Table 4.
The relationship of the genotypes of low molecular polypeptide-7 gene polymorphism within different liver fibrosis and activity stages in sustained virological response and non-response groups after treatment n (%)
| AA (n = 14) | CA (n = 42) | CC (n = 48) | P value | |
| F0 (n = 10) | 1 (10.00) | 2 (20) | 7 (70) | 0.045 |
| F1 (n = 29) | 4 (13.79) | 7 (24.14) | 18 (62.07) | 0.004 |
| F2 (n = 36) | 4 (11.11) | 14 (38.89) | 18 (50.00) | 0.013 |
| F3 (n = 23) | 4 (17.39) | 14 (60.87) | 5 (21.74) | 0.019 |
| F4 (n = 6) | 1 (16.67) | 5 (83.33) | 0 (0) | 0.1021 |
| A0 (n = 10) | 1 (11.11) | 1 (11.11) | 7 (77.78) | 0.018 |
| A1 (n = 29) | 9 (14.52) | 19 (30.65) | 34 (54.84) | 0.001 |
| A2 (n = 36) | 3 (11.11) | 18 (66.67) | 6 (22.22) | 0.001 |
| A3 (n = 6) | 1 (16.67) | 4 (66.67) | 1 (16.67) | 0.023 |
1
Not significant.